/explore
|
You are here 
|
www.theglobeandmail.com | ||
| | | | |
www.livenowthrivelater.co.uk
|
|
| | | | | It's commonly accepted that moderate alcohol consumption is not only innocuous, but potentially beneficial to one's health and longevity. That is to say that having 1-2 drinks, 3-4 days per week, isn't going to have negative effects on your health, and may even provide some benefits. A "new study", published last month in The Lancet, [...] | |
| | | | |
johnquiggin.com
|
|
| | | | | Another Monday Message Board. Post comments on any topic. Civil discussion and no coarse language please. Side discussions and idees fixes to the sandpits, please. I'm now using Substack as a blogging platform, and for my monthly email newsletter. For the moment, I'll post both at this blog and on Substack. You can also follow... | |
| | | | |
thezvi.wordpress.com
|
|
| | | | | Some amazing things are going on, not all of which involve mRNA, although please please those of you with the ability to do so, do your part to ensure that stays funded, either via investment or grants. As for mRNA, please do what you can to help save it, so we can keep getting more... | |
| | | | |
www.jci.org
|
|
| | | [AI summary] The provided text is a compilation of numerous scientific articles and studies, primarily focused on obesity, diabetes, and related metabolic disorders. The research spans a wide range of topics, including the role of gut hormones like GLP-1 and PYY in regulating food intake and glucose metabolism, the mechanisms of action of various drugs and peptides, and their therapeutic applications in managing metabolic diseases. Key areas of focus include the use of GLP-1 receptor agonists for weight loss and glycemic control, the potential of dual agonists targeting multiple receptors, and the exploration of endocrine signals such as GDF15 in nutritional stress. Additionally, the text touches on the physiological and pharmacological aspects of these inte... | ||
